Pharmacological AMP-kinase activators have compartment-specific effects on cell physiology

American Journal of Physiology - Cell Physiology

Volumn 301, Issue 6, 2011, Pages

  Kodiha, Mohamed ^a   Ho Wo Cheong, Dennis ^a   Stochaj, Ursula ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Acetyl CoA carboxylase; Nucleolus; Transcription

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ACETYL COENZYME A CARBOXYLASE; ADENYLATE KINASE; PHENFORMIN; RESVERATROL;

ALPHA CHAIN; ARTICLE; CELL COMPARTMENTALIZATION; CELL FRACTIONATION; CELL FUNCTION; CELL NUCLEUS; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CYTOPLASM; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME MODIFICATION; ENZYME PHOSPHORYLATION; IMMUNOLOCALIZATION; INTRACELLULAR SPACE; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SYNTHESIS;

ADENYLATE KINASE; AMINOIMIDAZOLE CARBOXAMIDE; BLOTTING, WESTERN; CELL LINE; CELL NUCLEUS; CYTOPLASM; ENZYME ACTIVATORS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICROSCOPY, CONFOCAL; PHENFORMIN; PHOSPHORYLATION; RIBONUCLEOTIDES; STILBENES;

EID: 82455192875     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00309.2011     Document Type: Article

References (54)

1. Baba Y, Nosho K, Shima K, Meyerhardt JA, Chan AT, Engelman JA, Cantley LC, Loda M, Giovannucci E, Fuchs CS, Ogino S. Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer. Br J Cancer 103: 1025-1033.
2. Boisvert FM, van Koningsbruggen S, Navascues J, Lamond AI. The multifunctional nucleolus. Nat Rev Mol Cell Biol 8: 574-585, 2007.
3. Bolster DR, Crozier SJ, Kimball SR, Jefferson LS. AMP-activated Protein Kinase Suppresses Protein Synthesis in Rat Skeletal Muscle through Down-regulated Mammalian Target of Rapamycin (mTOR) Signaling. J Biol Chem 277: 23977-23980, 2002.
4. Browne GJ, Finn SG, Proud CG. Stimulation of the AMP-activated Protein Kinase Leads to Activation of Eukaryotic Elongation Factor 2 Kinase and to Its Phosphorylation at a Novel Site, Serine 398. J Biol Chem 279: 12220-12231, 2004.
5. Canto C, Auwerx J. AMP-activated protein kinase and its downstream transcriptional pathways. Cell Mol Life Sci 67: 3407-3423, 2010.
6. Creighton J. Targeting therapeutic effects: subcellular location matters. Focus on "Pharmacological AMP-kinase activators have compartmentspecific effects on cell physiology." Am J Physiol Cell Physiol (September 28, 2011). doi:10.1152/ajpcell.00358.2011.
7. Daval M, Foufelle F, Ferré P. Functions of AMP-activated protein kinase in adipose tissue. J Physiol 574: 55-62, 2006.
8. Dorfman J, Macara IG. STRADa regulates LKB1 localization by blocking access to importin-alpha, and by association with Crm1 and exportin-7. Mol Biol Cell 19: 1614-1626, 2008.
9. Dyck JRB, Lopaschuk GD. AMPK alterations in cardiac physiology and pathology: enemy or ally? J Physiol 574: 95-112, 2006.
10. Dzamko NL, Steinberg GR. AMPK-dependent hormonal regulation of whole-body energy metabolism. Acta Physiol (Oxf) 196: 115-127, 2009.
11. Granot Z, Swisa A, Magenheim J, Stolovich-Rain M, Fujimoto W, Manduchi E, Miki T, Lennerz JK, Stoeckert CJ Jr, Meyuhas O, Seino S, Permutt MA, Piwnica-Worms H, Bardeesy N, Dor Y. LKB1 regulates pancreatic β cell size, polarity, and function. Cell Metab 10: 296-308, 2009.
12. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, Turk BE, Shaw RJ. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30: 214-226, 2008.
13. Hallows KR, Mount PF, Pastor-Soler NM, Power DA. Role of the energy sensor AMP-activated protein kinase in renal physiology and disease. Am J Physiol Renal Physiol 298: F1067-F1077, 2010.
14. Hardie DG. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obesity 32, Suppl 4: S7-S12, 2008.
15. Hardie DG, Hawley SA, Scott JW. AMP-activated protein kinase - development of the energy sensor concept. J Physiol 574: 7-15, 2006.
16. Hawley SA, Ross FA, Chevtzoff C, Green KA, Evans A, Fogarty S, Towler MC, Brown LJ, Ogunbayo OA, Evans AM, Hardie DG. Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab 11: 554-565, 2010.
17. Hoppe S, Bierhoff H, Cado I, Weber A, Tiebe M, Grummt I, Voit R. AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply. Proc Natl Acad Sci USA 106: 17781-17786, 2009.
18. Ix JH, Sharma K. Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol 21: 406-412, 2010.
19. Jordan SD, Konner AC, Bruning JC. Sensing the fuels: glucose and lipid signaling in the CNS controlling energy homeostasis. Cell Mol Life Sci 67: 3255-3273, 2010.
20. Kazgan N, Williams T, Forsberg LJ, Brenman JE. Identification of a nuclear export signal in the catalytic subunit of AMP-activated protein kinase. Mol Biol Cell 21: 3433-3442, 2010.
21. Kim AS, Miller EJ, Young LH. AMP-activated protein kinase: a core signalling pathway in the heart. Acta Physiol (Oxf) 196: 37-53, 2009.
22. Kitada M, Kume S, Imaizumi N, Koya D. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes 60: 634-643, 2011.
23. Kodiha M, Banski P, Stochaj U. Computer-based fluorescence quantification: a novel approach to study nucleolar biology. BMC Cell Biol 12: 25, 2011.
24. Kodiha M, Brown CM, Stochaj U. Analysis of signaling events by combining high-throughput screening technology with computer-based image analysis. Sci Signal 1: pl2, 2008.
25. Kodiha M, Rassi JG, Brown CM, Stochaj U. Localization of AMP kinase is regulated by stress, cell density, and signaling through the MEK->ERK1/2 pathway. Am J Physiol Cell Physiol 293: C1427-C1436, 2007.
26. Kodiha M, Stochaj U. AMP kinase -the missing link between type 2 diabetes and neurodegenerative diseases? Trends Mol Med. In press.
27. Kodiha M, Stochaj U. Targeting AMPK for therapeutic intervention in type 2 diabetes. In: Medical Complications of Type 2 Diabetes, edited by Croniger C. ISBN: 978-953-307-363-7. Rijeka, Croatia: InTech, 2011. [Available from http://www.intechopen.com/articles/show/title/targetingampk-for-therapeutic-intervention-in-type-2-diabetes].
28. Kodiha M, Tran D, Morogan A, Qian C, Stochaj U. Dissecting the signaling events that impact classical nuclear import and target nuclear transport factors. PLos One 4: e8420, 2009.
29. Lee MJ, Feliers D, Mariappan MM, Sataranatarajan K, Mahimainathan L, Musi N, Foretz M, Viollet B, Weinberg JM, Choudhury GG, Kasinath BS. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol 292: F617-F627, 2007.
30. Li J, McCullough LD. Effects of AMP-activated protein kinase in cerebral ischemia. J Cereb Blood Flow Metab 30: 480-492, 2010.
31. Li Q, Li J, Ren J. UCF-101 mitigates streptozotocin-induced cardiomyocyte dysfunction: role of AMPK. Am J Physiol Endocrinol Metab 297: E965-E973, 2009.
32. Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 116: 1776-1783, 2006.
33. Lopaschuk GD. AMP-activated protein kinase control of energy metabolism in the ischemic heart. Int J Obes 32: S29-S35, 2008.
34. McGee SL, Howlett KF, Starkie RL, Cameron-Smith D, Kemp BE, Hargreaves M. Exercise increases nuclear AMPK alpha2 in human skeletal muscle. Diabetes 52: 926-928, 2003.
35. Montanaro L, Trere D, Derenzini M. Nucleolus, ribosomes, and cancer. Am J Pathol 173: 301-310, 2008.
36. Nagata D, Hirata Y. The role of AMP-activated protein kinase in the cardiovascular system. Hypertens Res 33: 22-28, 2010.
37. Oakhill JS, Chen ZP, Scott JW, Steel R, Castelli LA, Ling N, Macaulay SL, Kemp BE. beta-Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK). Proc Natl Acad Sci USA 107: 19237-19241, 2010.
38. Quan X, Yu J, Bussey H, Stochaj U. The localization of nuclear exporters of the importin-beta family is regulated by Snf1 kinase, nutrient supply and stress. Biochim Biophys Acta 1773: 1052-1061, 2007.
39. Ramadori G, Gautron L, Fujikawa T, Vianna CR, Elmquist JK, Coppari R. Central administration of resveratrol improves diet-induced diabetes. Endocrinology 150: 5326-5333, 2009.
40. Reiter AK, Bolster DR, Crozier SJ, Kimball SR, Jefferson LS. AMPK represses TOP mRNA translation but not global protein synthesis in liver. Biochem Biophys Res Commun 374: 345-350, 2008.
41. Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S. AMPK in the brain: its roles in energy balance and neuroprotection. J Neurochem 109: 17-23, 2009.
42. Sanders MJ, Grondin PO, Hegarty BD, Snowden MA, Carling D. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem J 403: 139-148, 2007.
43. Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9: 563-575, 2009.
44. Steinberg GR, Kemp BE. AMPK in Health and Disease. Physiol Rev 89: 1025-1078, 2009.
45. Storz P, Doppler H, Toker A. Activation loop phosphorylation controls protein kinase D-dependent activation of nuclear factor B. Mol Pharmacol 66: 870-879, 2004.
46. Suzuki A, Okamoto S, Lee S, Saito K, Shiuchi T, Minokoshi Y. Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the α2 form of AMP-activated protein kinase. Mol Cell Biol 27: 4317-4327, 2007.
47. Szkudelski T, Szkudelska K. Anti-diabetic effects of resveratrol. Ann NY Acad Sci 1215: 34-39, 2011.
48. Thirunavukkarasu M, Penumathsa SV, Koneru S, Juhasz B, Zhan L, Otani H, Bagchi D, Das DK, Maulik N. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med 43: 720-729, 2007.
49. Turdi S, Fan X, Li J, Zhao J, Huff AF, Du M, Ren J. AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction. Aging Cell 9: 592-606, 2010.
50. Um JH, Park SJ, Kang H, Yang S, Foretz M, McBurney MW, Kim MK, Viollet B, Chung JH. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 59: 554-563, 2010.
51. Viollet B, Lantier L, Devin-Leclerc J, Hebrard S, Amouyal C, Mounier R, Foretz M, Andreelli F. Targeting the AMPK pathway for the treatment of Type 2 diabetes. Front Biosci 14: 3380-3400, 2009.
52. Wang T, Yu Q, Chen J, Deng B, Qian L, Le Y. PP2A mediated AMPK inhibition promotes HSP70 expression in heat shock response. PLos One 5: e13096, 2010.
53. Witczak C, Sharoff C, Goodyear L. AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism. Cell Mol Life Sci 65: 3737-3755, 2008.
54. Zhang BB, Zhou G, Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab 9: 407-416, 2009.